Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation
(Thomson Reuters ONE) -
Real-World Clinical Data is Key to Creating More Effective Medical Devices and
Enabling Better Patient Health
DUBLIN and ST. LOUIS - October 13, 2017 - Medtronic plc (NYSE: MDT), the global
leader in medical technology, and Mercy, the fifth largest Catholic health care
system in the U.S., together will establish a new data sharing and analysis
network that helps gather clinical evidence for medical device innovation and
patient access.
Traditional clinical trials can be complex, time consuming and costly. To
address this, Medtronic and Mercy Technology Services, the IT backbone of Mercy,
seek to co-develop a new way to answer questions about medical device safety and
patient outcomes through access to valuable clinical information captured during
routine patient care. In the initial phase, the new data network will capture
deidentified data from approximately 80,000 patients with heart failure to
explore real-world factors that determine a patient's response to Cardiac
Resynchronization Therapy (CRT) - a clinically proven heart failure treatment
option for some heart failure patients that is designed to help the lower
chambers of the heart beat together in a more synchronized pattern.
This coordinated data network aligns with the Food and Drug Administration's
vision to establish a National Evaluation System for health Technology (NEST).
With a national system, the FDA aims to quickly generate meaningful insights
from routine clinical care data. The partnership was recently selected by the
Medical Device Innovation Consortium as a Demonstration Project for its use of
scalable methods that generate real-world evidence. This project will ultimately
help shape the model for NEST to provide faster, more cost-effective regulatory
decisions and accelerated therapy innovation that keeps patients safer and
healthier.
"Having the ability to study patient care pathways and conditions before and
after exposure to a medical device is crucial to understanding how those devices
perform outside of the controlled clinical trial setting," said Dr. Rick Kuntz,
SVP of strategic scientific operations at Medtronic. "By partnering together,
Mercy and Medtronic have set out to create a comprehensive and economical
evidence generation model that ultimately allows patients to benefit from the
latest therapies and technologies as early as possible."
"This has the potential to improve patient care by using advanced data
analytics," said Dr. Joseph Drozda, Mercy's director of outcomes research.
"Heart failure is a complex, progressive condition. To more effectively treat
patients, we need a better understanding of how they are responding to treatment
and what leads to better health. This model will lead to evidence-based insights
for our clinical teams, and better health for our patients."
About Mercy
Mercy, named one of the top five large U.S. health systems in 2017 by Truven, an
IBM Watson Health company, serves millions annually. Mercy includes 44 acute
care and specialty (heart, children's, orthopedic and rehab) hospitals, more
than 700 physician practices and outpatient facilities, 40,000 co-workers and
more than 2,000 Mercy Clinic physicians in Arkansas, Kansas, Missouri and
Oklahoma. Mercy also has outreach ministries in Arkansas, Louisiana, Mississippi
and Texas.
About Mercy Technology Services
Mercy Technology Services provides and manages technology solutions for Mercy,
the nation's first health care provider accredited by Epic to offer a full suite
of EHR solutions to other hospitals, including Epic in the cloud, implementation
and optimization. MTS's award-winning data analytics integrate care delivery,
manage costs and support a model of care that keeps patients healthier and out
of the hospital.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among
the world's largest medical technology, services and solutions companies -
alleviating pain, restoring health and extending life for millions of people
around the world. Medtronic employs more than 84,000 people worldwide, serving
physicians, hospitals and patients in approximately 160 countries. The company
is focused on collaborating with stakeholders around the world to take
healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as
those described in Medtronic's periodic reports on file with the Securities and
Exchange Commission. Actual results may differ materially from anticipated
results.
-end-
Contacts:
Jeff Trauring
Public Relations
Medtronic plc
+1-763-505-0159
Ryan Weispfenning
Investor Relations
Medtronic plc
+1-763-505-4626
Nancy Corbett
Mercy Media Relations
+1-405-752-3793
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medtronic plc via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 13.10.2017 - 16:00 Uhr
Sprache: Deutsch
News-ID 563634
Anzahl Zeichen: 5773
contact information:
Town:
Dublin
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 592 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medtronic and Mercy Announce Data Sharing Partnership to Accelerate Medical Device Innovation"
steht unter der journalistisch-redaktionellen Verantwortung von
Medtronic plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
